Group 1 - Ferncliff Listed Dai AS sold 1,234,280 shares in Vistin Pharma ASA at NOK 22.50 per share on May 6, 2025 [1] - Saga Pure ASA sold 700,000 shares in Vistin Pharma ASA at NOK 22.50 per share on the same date [1] - After these transactions, both Saga Pure ASA and Ferncliff Listed Dai AS no longer hold shares in Vistin Pharma ASA [1] Group 2 - Øystein Stray Spetalen and associated parties hold 331,886 shares in Vistin Pharma ASA after the transactions, which is below 5% ownership [2] - Intertrade Shipping AS, associated with Chairman Øyvin A. Brøymer, purchased 1,934,280 shares at NOK 22.50 per share, matching the number of shares sold by Ferncliff Listed Dai AS and Saga Pure ASA [3] - Following this purchase, Intertrade Shipping AS holds a total of 14,509,280 shares, representing 32.72% of Vistin Pharma ASA [3]

Core Points - Vistin Pharma ASA will hold its Annual General Meeting on 22 May 2025 at 13:00 CEST [1] - The meeting will not be physical; shareholders are encouraged to authorize the Chairman of the Board and can use proxies with or without voting instructions [2] - The Election Committee's recommendations are available on the company's website and will be sent to all shareholders registered in the Norwegian Central Security Depository (VPS) [3] Additional Information - Attachments include the 2024 Annual Report, election committee proposal, and remuneration policy for executive management and board members [4]